AstraZeneca | Tennesseean.com

AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17

Mark Esser, PhD by Bill Snyder On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led…

Local News

AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

by Bill Snyder The global biopharmaceutical company AstraZeneca said Oct. 5 it has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt…